Lung infections associated with cystic fibrosis.
While originally characterized as a collection of related syndromes, cystic fibrosis (CF) is now recognized as a single disease whose diverse symptoms stem from the wide tissue distribution of the gene product that is defective in CF, the ion channel and regulator, cystic fibrosis transmembrane conductance regulator (CFTR). Defective CFTR protein impacts the function of the pancreas and alters the consistency of mucosal secretions. The latter of these effects probably plays an important role in the defective resistance of CF patients to many pathogens. As the modalities of CF research have changed over the decades from empirical histological studies to include biophysical measurements of CFTR function, the clinical management of this disease has similarly evolved to effectively address the ever-changing spectrum of CF-related infectious diseases. These factors have led to the successful management of many CF-related infections with the notable exception of chronic lung infection with the gram-negative bacterium Pseudomonas aeruginosa. The virulence of P. aeruginosa stems from multiple bacterial attributes, including antibiotic resistance, the ability to utilize quorum-sensing signals to form biofilms, the destructive potential of a multitude of its microbial toxins, and the ability to acquire a mucoid phenotype, which renders this microbe resistant to both the innate and acquired immunologic defenses of the host.
Lyczak
Jeffrey B
JB
Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Children's Hospital, Boston, MA 02115, USA.
Cannon
Carolyn L
CL
Pier
Gerald B
GB
D001424:Bacterial Infections / Q000382:microbiology*; D003550:Cystic Fibrosis / Q000235:genetics / Q000266:history / Q000382:microbiology* / Q000628:therapy; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D006193:Haemophilus influenzae / Q000302:isolation & purification; D049673:History, 20th Century; D006801:Humans; D008168:Lung / Q000382:microbiology*; D009154:Mutation; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000302:isolation & purification
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator